Combination therapy with hepatitis B vaccine and interferon alfa in chronic hepatitis B [4]

American Journal of Gastroenterology

Volumn 94, Issue 3, 1999, Pages 856-857

  Kaymakoglu, S ^a   Demir, K ^a   Cakaloglu, Y ^a   Tuncer, I ^a   Dincer, D ^a   Gurel, S ^a   Okten, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADULT; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MIXTURE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0032979434     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.0856a.x     Document Type: Letter

References (5)

1. 1 Lok ASF. Treatment of chronic hepatitis B. J Viral Hep 1994 ; 1: 105–24.
2. 2 Pol S, Driss F, Carnot F, et al. Immunotherapy through vaccination inhibits hepatitis B virus multiplication. Hepatology 1993 ; 18: 119A.DOI: 10.1016/0270-9139(93)92004-J
3. 3 Redfield RR, Birx DL. HIV‐specific vaccine therapy: concepts, status and future directions. AIDS Res Hum Retroviruses 1992 ; 8: 1051–8.
4. 4 Straus SE, Corey L, Burke RL, et al. Placebo‐controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 1994 ; 343: 1460–3. DOI: 10.1016/S0140-6736(94)92581-X
5. 5 Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 ; 1: 431–5.